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els improved as well. Quality of life increased during the 
telehealth intervention and disease knowledge remained 
high throughout the follow-up period. Unplanned admis-
sions that remained after telehealth introduction could be 
accurately predicted at baseline by a multivariate regression 
model.
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Introduction
Congestive heart failure (CHF) is a complex clinical syn-
drome, which represents an increasingly common health 
problem for patients, healthcare providers and reimburs-
ing agencies. The continuing ageing of the population is 
expected to increase the prevalence of heart failure in the 
Netherlands from 120,000 (~ 1 % of the population) in 2008 
to approximately 200,000 in the coming decade [1]. In 2011, 
the number of hospital admissions with heart failure as the 
primary discharge diagnosis was almost 30,000 [1]. Of all 
patients who were admitted once for heart failure, 14 % of 
them were re-admitted to the hospital within 6 months after 
their first index admission [2].
Guidelines of the European Society of Cardiology (ESC) 
recommend a multidisciplinary approach that coordinates 
care along the continuum of CHF, often implemented as in-
person follow-up visits [3]. Recently, alternative approaches 
such as telehealth and remote monitoring via cardiac 
implanted electronic devices [4, 5] have been proposed to 
assess physiological parameters related to CHF exacer-
bation more frequently, thereby enabling remote disease 
management [6]. Telehealth uses various information and 
communication technologies to assist in the management 
of an existing long-term medical condition of a patient at 
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home by delivering clinical care and non-clinical services, 
including education on the disease and the capture and 
transmission of questionnaire data and vital signs. However, 
the optimal approach to non-invasive remote monitoring is 
uncertain, and an ESC guideline recommendation is not yet 
supported because the randomised controlled trials (RCTs) 
performed to date have given inconsistent results [3].
Telehealth for heart failure has had mixed and heteroge-
neous effects across studies, necessitating further evaluation 
within specific healthcare systems and patient populations. 
A systematic review on telehealth efficacy in RCTs con-
cluded that telehealth reduced all-cause mortality by 34 % 
and CHF-related hospitalisations by 21 % and improvements 
in secondary endpoints such as quality of life and disease 
knowledge were also observed [7]. However, some stud-
ies included in the systematic review did not corroborate 
the beneficial effects of telehealth. The TEN-HMS study, 
the world’s first multi-centre RCT for telemonitoring in the 
UK, Germany and the Netherlands, showed that the use of 
telemonitoring reduced all-cause mortality by 29 % in a 240-
day follow-up, though this was not significant when compar-
ing with usual care [8]. In the HartMotief study, which was 
a multi-centre trial in eight Dutch hospitals, telemonitoring 
also failed to reduce mortality in a 288-day mean follow-up 
[9]. Furthermore, some later studies were not able to demon-
strate telehealth efficacy. In the TIM-HF study, telehealth was 
implemented by means of a call centre and compared with an 
already excellent conventional care. In this study, telehealth 
failed to reduce all-cause mortality or a combined endpoint 
of cardiovascular mortality or hospitalisation in a mean fol-
low-up of 21 months [10]. The Tele-HF study was unable to 
show reduction in mortality and admission for a structured 
telephone support system in a 6-month follow-up [11]. Poor 
patient compliance may have had an impact on the findings, 
as the use of the system was laborious for end users. The 
Whole System Demonstrator (WSD), a large RCT of tele-
health involving 3230 patients with CHF, chronic obstructive 
pulmonary disease or diabetes mellitus in the UK, showed 
that telemonitoring lowered mortality and emergency admis-
sions by 45 and 20 %, respectively, in comparison with usual 
care in a 1-year follow-up [12]. Cost-effectiveness analysis 
of WSD results did not show telehealth to be a cost-effective 
alternative to usual care [13], but unfortunately the decrease 
in mortality in the telehealth group was not taken into account 
in this analysis. Even though most available data suggest that 
telehealth is a promising strategy for improving disease man-
agement of CHF patients, more data are needed to determine 
the most advantageous approaches.
The first objective of this study was to assess the impact of 
telehealth-based disease management on unplanned admis-
sions, disease severity and quality of life in CHF patients. 
The unique aspect of this study was its setting: a single 
community hospital in the north of the Netherlands, where 
cardiologists and nurse practitioners collaborate within the 
hospital outpatient heart failure unit. Furthermore, primary 
care, local home care agencies and nursing homes play a key 
role in the care protocol of CHF patients through their gen-
eral practitioners, home care nurses and physicians. The sec-
ond objective was to determine, which patient characteristics 
were predictive of unplanned admissions in a telehealth pro-
gram. As unplanned readmissions are costly, a predictive 
score to quantify the risk of readmission would help clini-
cians to identify patients who might benefit from more inten-
sive post-discharge care, even beyond telemonitoring.
Materials and methods
Study design
In this prospective study, 102 CHF patients were enrolled in 
an optimised care program with telehealth between 3 April 
2011 and 10 May 2013. A pre-post study design was used 
to evaluate the effect of the telehealth intervention without 
the use of a control group. The primary outcome, number 
of unplanned hospitalisations for heart failure, was mea-
sured 1 year before and 1 year after introduction of the pro-
gram. Unplanned admissions were considered admissions 
that could not be delayed beyond 24 h because of symp-
toms ascribed to heart failure by the attending physician or 
nurse practitioner. Secondary outcomes, blood pressure and 
NT-proBNP levels, were measured at enrolment and after 
3, 6 and 12 months. Blood pressure was measured using 
an automatic upper arm cuff (A&D Medical, San Jose, CA, 
USA). NT-proBNP analysis was performed with an immu-
noassay (Elecsys proBNP, Roche Diagnostics, Almere, the 
Netherlands).
Patients discharged after an admission with the primary 
diagnosis of heart failure or outpatients after an episode of 
new or worsening heart failure, as judged by the attending 
cardiologist because of clinical symptoms and NT-proBNP 
levels elevated above normal limits, were recruited to par-
ticipate in the study. Patients who were in New York Heart 
Association (NYHA) class II–IV, were in a stable condi-
tion, had good command of the Dutch language and were 
in possession of a television set were eligible for inclu-
sion. Patients who were unable to provide informed con-
sent were excluded from the study. Out of 105 patients who 
were asked to participate in the study, 102 (97 %) gave their 
informed consent.
The study was conducted in a CHF outpatient unit of a 
local community hospital in the north of the Netherlands 
(Scheper Hospital, Emmen, the Netherlands). The unit’s 
cardiologists and nurse practitioners provide care to heart 
failure patients in the region, involving the patient’s general 
practitioner, nurses from a local home care agency and phy-
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of life due to heart failure and its treatment [15]. DHFKS 
covers items concerning heart failure knowledge in general, 
knowledge on heart failure treatment and symptoms [16]. 
Based on the answers, the nurse practitioner could decide to 
send the patient a video he/she believed could be valuable 
for the patient to review.
Statistical analysis
The number of unplanned admissions for heart failure in the 
period of 12 months before telemonitoring (the index admis-
sions were not included in the counts) was compared with 
the number of admissions in the period of 12 months after 
telemonitoring was introduced with a rate ratio test [17]. 
The incidence rate ratio is the rate of unplanned admissions 
in the pre-phase divided by the rate of unplanned admissions 
in the post-phase. The rate ratio test tests the null-hypothesis 
that the incidence rate ratio is equal to 1.0.
Repeated measures analysis of variance (ANOVA) fol-
lowed by Tukey’s post-hoc comparison of means using 
α = 0.05 was used to determine significant deviations in 
blood pressure, NT-proBNP levels, knowledge level and 
quality of life from baseline. The method by Cousineau 
[18] was used to derive 95 % confidence intervals (CIs) for 
visualisation in charts. Repeated measures ANOVA was car-
ried out to test for the effect of medication use and time on 
the telehealth program on blood pressure. The interaction 
between medication use and time on telehealth was included 
in this analysis to determine if the decrease in blood pres-
sure over time was affected by medication.
It was further determined that patient characteristics at 
baseline could be used to provide a prediction of unplanned 
admission for heart failure within 12 months. A multivariate 
logistic regression model was developed on data from 80 
patients chosen at random. The model variables were chosen 
using a forward selection approach, where the criterion used 
was to maximise the area under the receiver operator char-
acteristic curve (AUC). Furthermore, to more accurately 
account for the non-linear relation between age and out-
come, both age and age squared were included as predictors 
in the model. A cut-off level for NT-proBNP of 2500 pg/l 
was used to model the increased outcome in patients with 
NT-proBNP levels beyond 2500 pg/l. The model was evalu-
ated using the AUC on the hold-out set of 22 patients.
Results
Baseline
Out of 105 heart failure patients considered eligible, 102 
patients (97 %) gave informed consent. Patients were 
on average 75 ± 12 years and 60 % were female patients 
sicians at the nursing home, if patients reside at such facili-
ties. This structured service was already in place before 
patients were enrolled in the telehealth program. A detailed 
schematic diagram of the optimised care pathway including 
telehealth can be found elsewhere [14].
Staff had prescription and treatment authorisation, pre-
venting delay in response-treatment times and preventing 
burden on the workload of the cardiologist. The telemoni-
toring system was used to obtain and check patient vital sign 
measurements (blood pressure, pulse, weight) on a daily 
basis. All members of the cardiology department had access 
to the telemonitoring system, allowing them to check vital 
sign measurements at every moment and react accordingly.
Retrospective data of 1 year on CHF-related admissions 
were gathered as well as demographics, clinical status and 
treatment and physical examination data. All patients were 
followed up for a period of 1 year with additional visits as 
required in case of deterioration. Follow-up visits at the 
outpatient unit took place 3, 6 and 12 months (study end) 
after enrolment. The nurse practitioners and cardiologists 
participating in the study were the same as those involved 
in the patients’ everyday care before the study. During the 
study period, all patients continued to receive the standard 
care provided to patients at the CHF outpatient unit. Patients 
received primary care from their own general practitioner.
The study was approved by the hospital ethics commit-
tee. All participants gave informed written consent.
Telehealth intervention
The Motiva telehealth system (Philips Healthcare, Best, the 
Netherlands) was used and included a secured broadband 
home TV channel providing educational material, remind-
ers of medication, health-related surveys and motivational 
messages to encourage the prescribed lifestyle regimen. 
Patients were given automated devices for daily measure-
ments of blood pressure, heart rate and weight at home. A 
nurse practitioner evaluated the measurements every day 
using a dedicated clinical user interface. With tailored alarm 
settings, the nurse practitioner could identify which patients 
exceeded the alarm limits and needed extra attention. The 
situation was evaluated with a phone call or extra visit and if 
necessary the nurse practitioner altered the treatment.
Patients also received scheduled educational videos 
covering topics such as symptoms, daily care, aetiology, 
medication, compliance, relapse prevention, cholesterol 
management, hypertension, lifestyle, nutrition, vaccina-
tions and alcohol consumption. Questionnaires on quality 
of life (Minnesota Living with Heart Failure, MLHF) and 
disease knowledge (Dutch Heart Failure Knowledge Sur-
vey, DHFKS) were sent every 8 and 12 weeks, respectively. 
MLHF measures the effects of symptoms, functional limita-
tions and psychological distress on an individual’s quality 
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while only 31 patients (30 %) had one or more admissions 
in the post-phase. The number of days spent in hospital for 
all-cause admissions decreased from 975 in the 12 months 
before telehealth enrolment to 662 in the 12 months after 
telehealth introduction.
Clinical effects of the telehealth program were deter-
mined by measuring systolic and diastolic blood pressure 
and NT-proBNP levels at baseline and after 3, 6 and 12 
months in the program (Table 2). All 102 patients had 4 fol-
low-ups, but systolic blood pressure was not recorded in 29 
cases, diastolic blood pressure was not recorded in 31 cases 
and NT-proBNP level was not recorded in 55 cases. Sys-
tolic blood pressure decreased significantly by 7.9 mmHg 
(F(3,281) = 25.1, p < 0.001), while diastolic blood pressure 
decreased significantly by 5.0 mmHg (F(3,279) = 22.6, 
p < 0.001) after 12 months in the telehealth program as com-
pared with baseline. For NT-proBNP level, a significant 
decrease over time was found from 4433 ± 5720 at base-
line to 2877 ± 3128 pg/l at 12 months, a reduction of 35 % 
(F(3,250) = 10.9, p < 0.001).
A total of 67 patients (66 %) were prescribed both 
β-blockers and ACE inhibitors. In patients using both medi-
cations, systolic blood pressure was significantly lower 
than in other patients (F(1,93) = 10.2, p < 0.05), but diastolic 
blood pressure was not (F(1,93) = 1.2, p = 0.28). Repeated 
measures ANOVA including the interaction between use 
of both medications and time on the telehealth program 
demonstrated that the combination of β-blockers with ACE 
inhibitors did not have a statistically significant effect on the 
decrease in systolic blood pressure (F(3,278) = 1.2, p = 0.31) 
or diastolic pressure (F(3,276) = 1.1, p = 0.33) over time 
(Fig. 1).
Quality of life and disease knowledge
Quality of life was assessed by the MLHF survey with 
complete observations in 86 patients; a higher MLHF score 
corresponds to a lower quality of life. Mean total MLHF 
scores decreased over time (Fig. 2), which was found to be 
(Table 1). The majority of heart failure cases were a result 
of ischaemic heart disease. In this population, 74 patients 
(73 %) were in NYHA class III or IV and NT-proBNP val-
ues averaged 4433 pg/l. Implantable pacing devices were 
present in 36 % of the patients; 89 % of patients had valvu-
lar disease and nearly half of patients had atrial fibrillation. 
Medication treatment at baseline covered most patients and 
can be considered excellent with 80 % of the patients on 
beta-blockers, 94 % on diuretics and 78 % on angiotensin-
converting enzyme (ACE) inhibitors.
Clinical outcomes
There were 132 unplanned admissions for heart failure 
in the 12 months before telehealth enrolment, or an aver-
age of 1.29 admissions per patient in the pre-phase. In 
the 12 months after telehealth introduction, there were 32 
unplanned heart failure admissions, or on average 0.31 per 
patient, i.e. a reduction of 76 % in unplanned heart failure 
admissions. The incidence rate ratio was found to be statisti-
cally significantly different from 1 (rate ratio: 4.1, 95 % CI: 
[2.8–6.3], p < 0.001). In the pre-phase, 87 patients (85 %) 
had one or more unplanned admissions for heart failure, 
Table 1 Baseline characteristics of the 102 heart failure patients
Age 75 ± 12 Years (47–91)
Gender
 Female 61 (60 %)
 Male 41 (40 %)
Heart failure aetiology
 Ischaemic 62 (61 %)
 Non-ischaemic 40 (39 %)
NYHA class
 II 28 (27 %)
 III 57 (56 %)
 IV 17 (17 %)
eGFR 49.0 ± 12.0 ml/min
Blood pressure/heart rate
 Systolic 128.3 ± 16.1 mmHg
 Diastolic 77.6 ± 14.0 mmHg
 Pulse 73.4 ± 15.3 bpm
N-terminal pro-B-type natriuretic peptide 4433 ± 5720 pg/l
Medications
 β-blockers 82 (80 %)
 Diuretics 96 (94 %)
 ACE inhibitors 80 (78 %)
Implantable devices 37 (36 %)
Affected valves
 Mitral 89 (87 %)
 Aortic 16 (16 %)
 Tricuspid 59 (58 %)
Atrial fibrillation 47 (46 %)
NYHA New York Heart Association, eGFR estimated glomerular 
filtration rate, ACE angiotensin-converting enzyme
Table 2 Population means ± standard deviation of systolic and dia-
stolic blood pressure and N-terminal pro-B-type natriuretic peptide 
(NT-proBNP) values in 102 patients at baseline and during the tele-
health program
Baseline 3 Months 6 Months 12 Months
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Predictive analysis
A total of 31 patients (30 %) had one or more admissions 
for heart failure. Odds ratios for the multivariate logistic 
regression model are given in Table 3. AUC for the model 
development set was 0.90 and the AUC for the hold-out set 
was 0.93.
statistically significant starting from 24 weeks after base-
line (F(6,510) = 4.6, p < 0.001). Disease knowledge was 
assessed by the DHFKS survey with complete observations 
in 88 patients. The reported knowledge level was found 
to be consistently high across all follow-up times from 
12.2 ± 0.5 at baseline to 11.5 ± 0.4 at 48 weeks (Fig. 2). The 
knowledge level at baseline was slightly but significantly 
higher than the knowledge level during the first follow-up 
(F(4,348) = 3.3, p < 0.05). There were no significant differ-
ences with baseline at the other follow-up times.
Fig. 1 Systolic and diastolic 
blood pressure in patients who 
were prescribed both β-blockers 
and angiotensin-converting 
enzyme inhibitors compared with 
the remaining patients. Error bars 
represent within-subject 95 % 
confidence intervals. * statisti-
cally significantly different from 
baseline (p < 0.05). # statistically 
significantly different from pa-
tients without both medications
 
Fig. 2 Mean responses to the 
Minnesota Living with Heart 
Failure (MLHF) and Dutch 
Heart Failure Knowledge Survey 
(DHFKS) questionnaires at dif-
ferent follow-up times. DHFKS 
scores range from 0 to 15 with 
a high score reflecting better 
disease knowledge. MLHF scores 
range from 0 to 105 with a low 
score reflecting a better health-
related quality of life. Error bars 
represent within-subject 95 % 
confidence intervals. * statisti-
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patient medical records for the staff who monitored the data 
to be a crucial factor in care coordination.
Predicting admissions in heart failure patients is difficult 
[28]; however, we showed that unplanned admissions in the 
next 12 months could be accurately predicted from baseline 
measurements for CHF patients who were in the telehealth 
program using multivariable logistic regression. Strong pre-
dictors included NYHA class IV and elevated NT-proBNP 
levels, which are indicative of increased disease severity. 
Emergency admissions may not be avoidable by a telehealth 
program alone in these patients.
Main limitation of the current study is the pre-post design 
without a control group. Therefore, one needs to be cautious 
when interpreting these results as being brought about by the 
telehealth program. The number of admissions on remea-
surement is likely to be lower due to the statistical phenom-
enon of regression to the mean. An estimation of this effect 
[29] led us to believe that only 17 % of the observed reduc-
tion in unplanned admissions could have been explained 
by this effect. Furthermore, a learning effect may have 
occurred by sending the MLHF and DHFKS questionnaires 
every 8 and 12 weeks. In addition, based on the answers of 
the DHFKS, the nurse practitioner could decide to send the 
patient a relevant educational video. This may have influ-
enced the DHFKS score as an outcome measure.
In the Netherlands, virtually all hospitals work with a 
CHF clinic staffed with either nurses or nurse practitioners, 
as it is a performance indicator monitored by the Dutch 
Healthcare Inspectorate [30]. Provided patient records 
are electronically available, the use of telemonitoring and 
implementation of its data in day-to-day care can be done 
without a substantial increase in workload for the nursing 
staff. However, contrary to nurse practitioners, nurses are 
not allowed to prescribe medication, which could impair a 
quick response.
In future, we are looking to further expand the current 
optimised care program with telehealth to other hospitals 
in the region. However, the inadequacy of reimbursing sys-
tems in the Netherlands to pay for this type of coordinated 
care constitutes a potential threat to its wider implementa-
tion, thereby possibly withholding improved chronic care 
from patients who could benefit and missing the opportunity 
to reduce overall costs of the care for CHF patients.
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Discussion
In line with previous findings [19], the number of unplanned 
admissions for heart failure decreased in patients enrolled 
in a disease management program after telemonitoring 
was added to the program. Furthermore, blood pressure 
decreased independently of medication and NT-proBNP 
level decreased significantly, a trend that was observed ear-
lier in internet-based home monitoring [20]. Finally, dis-
ease-specific knowledge was maintained at a high level and 
quality of life increased during the telehealth intervention.
Interventions using telehealth technology have the poten-
tial to reduce avoidable readmissions, and the evidence base 
for its beneficial effect is growing [12, 21]. However, vari-
ous previous RCTs on the effect of telehealth showed disap-
pointing results [10, 11, 22]. For instance, in the TEHAF 
study, the combined endpoint of heart failure admission and 
all-cause mortality was similar for both control and inter-
vention groups. This could be in part attributed to already 
excellent care management in the control groups of these 
studies [23]. While multicentre RCTs are the gold standard 
of clinical evidence, a rigorous RCT is also very restrictive 
and telehealth results may be more superior when there is 
freedom in the implementation [24]. Therefore, reporting 
the results of this local telehealth project may contribute to 
the further development and critical evaluation of these sys-
tems in daily practice.
By providing education to promote change in patient 
behaviour for proper self-management, telehealth may have 
improved clinical indicators and quality of life [25]. Blood 
pressure readings improved over time in line with previous 
findings (see Paré et al. [26] for a review). We did not inves-
tigate if any medication adjustments triggered by telemoni-
toring affected blood pressure. Continuous surveillance of 
vital sign data in addition to usual care allowed for an imme-
diate and adequate response to deviations from the accepted 
limits. As described previously [27], we found access to 
Table 3 Odds ratios of variables in the multivariable logistic regres-
sion model predicting unplanned admissions for heart failure in the 
next 12 months
Model variable Odds ratio 95 % CI
Age 8.0* 2.8-23.1
Age2 0.98* 0.98-0.99
NYHA class IV 32.2* 1.4-722.8
N-terminal pro-B-type natriuretic peptide 
> 2500 pg/l
11.8* 1.5-89.9
Any implantable pacing device 0.10* 0.02-0.64
Heart failure admissions in past 12 months 8.3* 2.4-29.1
95 % confidence intervals (CI) are given
Model was developed using data from 80 randomly selected patients
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